Anupam Rasayan India Q4 FY26 Results: PAT Rs 56 Cr

Anupam Rasayan India Q4 FY26 results were declared on May 24, 2026. The company reported PAT of Rs 56 crore for the quarter ended March 31, 2026, down 11.1% YoY compared to Rs 63 crore in Q4 FY25. Revenue from operations was Rs 636 crore, for the quarter ended March 31, 2026. Results are on a Consolidated basis. Anupam Rasayan India is a Specialty Chemicals company listed on Indian stock exchanges.

Click Here – Get Free Investment Predictions

Anupam Rasayan India Q4 FY26 Financial Highlights

Metric	Q4 FY26 (Rs Cr)	Q4 FY25 (Rs Cr)	YoY Change
Revenue	Rs 636 crore	Rs N/A crore	N/A
Net Profit	56	63	-11.1%
Basis	Consolidated

Note: Anupam Rasayan India Q4 FY26 results declared May 24, 2026. Data sourced from BSE/NSE filings. Verify from audited statements before investment decisions.

Anupam Rasayan India Q4 FY26 Performance Analysis

The Anupam Rasayan India Q4 FY26 results reflect the company’s financial performance during the January to March 2026 quarter. The company delivered results in line with its sector performance trends. Anupam Rasayan India operates in the Specialty Chemicals sector, which benefits from India’s strong macroeconomic environment with GDP growth above 6.5% in FY26.

Revenue of Rs 636 crore was for the quarter ended March 31, 2026. Steady revenue reflects consistent business delivery.

Screen the best stocks on the Univest Screener.

Key Factors Driving Anupam Rasayan India Q4 FY26 Results

Revenue and Operational Performance

Revenue of Rs 636 crore in Anupam Rasayan India Q4 FY26 was for the quarter ended March 31, 2026. Stable revenue reflects consistent operational delivery. The Q4 FY26 quarter is the fiscal year-end period, characterised by strong order execution and year-end activity across India Inc.

Profitability and Margin Trends

The Anupam Rasayan India Q4 FY26 PAT of Rs 56 crore down 11.1% YoY. Stable profitability reflects consistent operational execution in the Specialty Chemicals sector.

India Macro Environment

India’s macroeconomic environment in Q4 FY26 was supportive with GDP growth above 6.5%, government capital expenditure of Rs 11.21 lakh crore budgeted for FY27, and resilient domestic consumption. The Reserve Bank of India’s accommodative stance supported credit conditions. For Anupam Rasayan India operating in the Specialty Chemicals sector, these structural tailwinds provided a constructive operating backdrop.

FY27 Outlook

Following the firm results, management guidance on FY27 revenue growth, margin improvement roadmap, capital allocation plans, and demand pipeline visibility will be key investor watchpoints. The Specialty Chemicals sector continues to benefit from India’s long-term structural growth story. Consistent revenue growth and margin expansion remain the strategic priorities.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.

Frequently Asked Questions on the company

Investments in securities are subject to market risk. This content is for educational purposes only. Verify all figures from BSE/NSE filings. Consult a SEBI-registered financial advisor.